312 related articles for article (PubMed ID: 18005178)
41. Control of vancomycin-resistant enterococci: one size fits all?
Armeanu E; Bonten MJ
Clin Infect Dis; 2005 Jul; 41(2):210-6. PubMed ID: 15983917
[TBL] [Abstract][Full Text] [Related]
42. Rate of nosocomial transmission of vancomycin-resistant enterococci from isolated patients.
Cheng AC; Harrington G; Russo P; Liolios L; Spelman D
Intern Med J; 2004 Aug; 34(8):510-2. PubMed ID: 15317552
[TBL] [Abstract][Full Text] [Related]
43. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital.
Ergani-Ozcan A; Naas T; Baysan BO; Ogunc D; Inan D; Colak D; Nordmann P
J Antimicrob Chemother; 2008 May; 61(5):1033-9. PubMed ID: 18319236
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
Zaas AK; Song X; Tucker P; Perl TM
Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
[TBL] [Abstract][Full Text] [Related]
45. [VCA agar (bioMérieux) for selective isolation of vancomycin-resistant Enterococci (VRE) from fecal specimens].
Delmas J; Robin F; Romaszko JP; Baraduc R; Lesens O; Sirot J; Bonnet R
Pathol Biol (Paris); 2005; 53(8-9):485-9. PubMed ID: 16084029
[TBL] [Abstract][Full Text] [Related]
46. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies.
Furtado GH; Mendes RE; Pignatari AC; Wey SB; Medeiros EA
Am J Infect Control; 2006 Sep; 34(7):447-51. PubMed ID: 16945692
[TBL] [Abstract][Full Text] [Related]
48. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients.
Batistão DW; Gontijo-Filho PP; Conceição N; Oliveira AG; Ribas RM
Mem Inst Oswaldo Cruz; 2012 Feb; 107(1):57-63. PubMed ID: 22310536
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of vancomycin-resistant Enterococcus cases at a tertiary level hospital in Izmir, Turkey].
Atalay S; Ece G; Samlıoğlu P; Maraş G; Köse I; Köse S
Mikrobiyol Bul; 2012 Oct; 46(4):553-9. PubMed ID: 23188569
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections.
Joels CS; Matthews BD; Sigmon LB; Hasan R; Lohr CE; Kercher KW; Norton J; Sing RF; Heniford BT
Am Surg; 2003 Jun; 69(6):514-9. PubMed ID: 12852510
[TBL] [Abstract][Full Text] [Related]
51. A mathematical model quantifying the impact of antibiotic exposure and other interventions on the endemic prevalence of vancomycin-resistant enterococci.
D'Agata EM; Webb G; Horn M
J Infect Dis; 2005 Dec; 192(11):2004-11. PubMed ID: 16267774
[TBL] [Abstract][Full Text] [Related]
52. First report of clinical and epidemiological characterisation of vancomycin-resistant enterococci from mainland China.
Cao B; Liu Y; Song S; Li R; Wang H; Wang C
Int J Antimicrob Agents; 2008 Sep; 32(3):279-81. PubMed ID: 18614337
[No Abstract] [Full Text] [Related]
53. Vancomycin resistant enterococci healthcare associated infections.
Orsi GB; Ciorba V
Ann Ig; 2013; 25(6):485-92. PubMed ID: 24284534
[TBL] [Abstract][Full Text] [Related]
54. Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.
Lucet JC; Armand-Lefevre L; Laurichesse JJ; Macrez A; Papy E; Ruimy R; Deblangy C; Lozach A; Lolom I; Jarlier V; Andremont A; Leport C
J Hosp Infect; 2007 Sep; 67(1):42-8. PubMed ID: 17719129
[TBL] [Abstract][Full Text] [Related]
55. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.
Weinstock DM; Conlon M; Iovino C; Aubrey T; Gudiol C; Riedel E; Young JW; Kiehn TE; Zuccotti G
Biol Blood Marrow Transplant; 2007 May; 13(5):615-21. PubMed ID: 17448922
[TBL] [Abstract][Full Text] [Related]
56. New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission.
Tacconelli E
Clin Microbiol Infect; 2006 Feb; 12(2):102-9. PubMed ID: 16441446
[TBL] [Abstract][Full Text] [Related]
57. Healthcare-associated risk factors of vancomycin-resistant Enterococci colonization among outpatients undergoing hemodialysis.
Kee SY; Park CW; Lee JE; Kwon YJ; Pyo HJ; ; Kim WJ; Cheong HJ
Jpn J Infect Dis; 2012; 65(1):57-60. PubMed ID: 22274159
[TBL] [Abstract][Full Text] [Related]
58. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia.
Price CS; Paule S; Noskin GA; Peterson LR
Clin Infect Dis; 2003 Oct; 37(7):921-8. PubMed ID: 13130403
[TBL] [Abstract][Full Text] [Related]
59. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
[TBL] [Abstract][Full Text] [Related]
60. Clostridium difficile and vancomycin-resistant enterococcus: the new nosocomial alliance.
Poduval RD; Kamath RP; Corpuz M; Norkus EP; Pitchumoni CS
Am J Gastroenterol; 2000 Dec; 95(12):3513-5. PubMed ID: 11151886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
